Pharmacokinetics (PK) of Dalfampridine-ER 7.5 mg BID in Healthy Volunteers and Subjects With Mild or Moderate Renal Impairment
| Status: | Archived |
|---|---|
| Conditions: | Renal Impairment / Chronic Kidney Disease |
| Therapuetic Areas: | Nephrology / Urology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | January 2011 |
| End Date: | November 2011 |
A Parallel, Three Arm, Open-label, Multi-dose Pharmacokinetic Study of Dalfampridine-ER 7.5 mg Twice Daily in Both Healthy Volunteers and Those With Mild and Moderate Renal Impairment
To characterize the single dose and steady-state pharmacokinetics of Dalfampridine-ER 7.5 mg
tablets in healthy adult volunteers and those with mild and moderate renal impairment, and
examine between group comparisons.
Pharmacokinetics in normal, mildly renally impaired, and moderately renally impaired
subjects
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials